We, and others, have previously shown changes in the gut microbiome in association with metabolic and CVD
Because it does not suppress appetite, it can theoretically be combined with GLP-1 agonists to add a lipolytic component to the appetite suppression mechanism, though clinical data on this combination is lacking
It is not approved or intended for human or animal use, ingestion, dosing, or therapeutic application
DR ROSSI: Is that like dialysis in kidney, renal function
Frisco Spinal Rehab 3535 Victory Group Way, Ste 310 Frisco, TX 75034 (972) 712-7744 FriscoRehab.com For educational purposes only
[6] In all cases, a healthcare provider should evaluate patient history for any contraindication before initiating therapy